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Abstract 22 
Nitrate-rich beetroot juice (BRJ) increases plasma nitrite concentration, lowers the oxygen cost 23 
(V̇O2) of steady-state exercise and improves exercise performance in sedentary and 24 
moderately-trained, but rarely in well-trained individuals exercising at sea-level. BRJ 25 
supplementation may be more effective in a hypoxic environment, where the reduction of 26 
nitrite into nitric oxide (NO) is potentiated, such that well-trained and less well-trained 27 
individuals may derive a similar ergogenic effect.   We conducted a randomised, 28 
counterbalanced, double-blind placebo controlled trial to determine the effects of BRJ on 29 
treadmill running performance in moderate normobaric hypoxia (equivalent to 2500 m altitude) 30 
in participants with a range of aerobic fitness levels. Twelve healthy males (V̇O2max ranging 31 
from 47.1 - 76.8 ml·kg-1·min-1) ingested 138 ml concentrated BRJ (~ 15.2 mmol nitrate) or a 32 
nitrate-deplete placebo (PLA) (~ 0.2 mmol nitrate).  Three hours later, participants completed 33 
steady-state moderate intensity running, and a 1500 m time-trial (TT) in a normobaric hypoxic 34 
chamber (FIO2 ~15 %).  Plasma nitrite concentration was significantly greater following BRJ 35 
versus PLA 1 hour post supplementation, and remained higher in BRJ throughout the testing 36 
session (p < 0.01). Average V̇O2 was significantly lower (BRJ: 18.4 ± 2.0, PLA: 20.4 ± 12.6 37 
ml·kg-1·min-1; p = 0.002), whilst arterial oxygen saturation (SaO2) was significantly greater 38 
(BRJ: 88.4 ± 2.7, PLA: 86.5 ± 3.3 %; p < 0.001) following BRJ.  BRJ improved TT 39 
performance in all 12 participants by an average of 3.2 % (BRJ: 331.1 ± 45.3 vs. PL: 341.9 ± 40 
46.1 s; p < 0.001). There was no apparent relationship between aerobic fitness and the 41 
improvement in performance following BRJ (r2 = 0.05, p > 0.05). These findings suggests that 42 
a high nitrate dose in the form of a BRJ supplement may improve running performance in 43 
individuals with a range of aerobic fitness levels conducting moderate and high-intens ity 44 
exercise in a normobaric hypoxic environment. 45 
Key words: Nitric Oxide, Nitrate, Exercise performance, Hypoxia 46 
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1. Introduction 47 
Supplementation with dietary nitrate via nitrate-rich foods or nitrate salts elicits an array of 48 
potentially beneficial physiological changes.  These include, but are not restricted to: lower 49 
blood pressure [1–3], reduced O2 consumption (V̇O2) during steady-state exercise [4–6], 50 
attenuated muscle metabolic perturbations [7,8], and enhanced muscle force production [9,10]. 51 
These effects are not directly attributable to the nitrate anion, which is relatively inert [11].  52 
Instead, the benefits of nitrate supplementation appear to be related to an increased production 53 
of the multifunctional signalling molecule nitric oxide (NO).  Ingested nitrate is reduced to 54 
nitrite by symbiotic bacteria residing predominantly on the dorsal surface of the tongue [12,13]. 55 
A portion of the nitrite is converted into NO in the acidic environment of the stomach [14,15], 56 
but the majority enters systemic circulation where it may be reduced to NO and other bioactive 57 
nitrogen oxides in the blood and tissue via various nitrite reductases [11].   58 
 59 
Increasing NO bioavailability via nitrate supplementation has been reported to improve 60 
exercise time to exhaustion (TTE) or time-trial (TT) performance in the majority [5,16–18], 61 
but not all [23,24] previous investigations in untrained and moderately-trained individua ls. 62 
Conversely, well-trained participants (V̇O2max > 60 ml·kg-1·min-1) are typically less responsive 63 
to dietary nitrate supplementation [17,19–21,25–27], even when very high nitrate doses (~ 19.5 64 
mmol) are administered [28].  Highly-trained individuals are known to possess elevated 65 
baseline nitrate/ nitrite reserves [29], may habitually consume large amounts of nitrate, 66 
subsequent to their increased calorie consumption [30], and exhibit greater presence and 67 
activity of the NOS enzymes, relative to the untrained [31].  Such differences may reasonably 68 
be expected to lessen the ergogenic effect of nitrate supplementation [30].   69 
 70 
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The reduction of nitrite to NO, and hence the capacity to influence NO mediated physiologica l 71 
processes, is potentiated when muscle pH [32] and PO2 [33] decline.  Conversely, the L-72 
arginine NOS pathway becomes dysfunctional with low O2 tensions and pH [33].  Such cellular 73 
conditions are likely to be especially prevalent during exercise in a hypoxic environment [8,34], 74 
such as experienced on ascent to terrestrial altitude.  This suggests that nitrate supplementa t ion 75 
may be more likely to enhance NO generation and therefore improve performance in hypoxia 76 
relative to normoxia.  Moreover, an improvement in mitochondrial [35] and/ or muscle 77 
contractile efficiency [7] subsequent to nitrate supplementation which reduces V̇O2 is likely to 78 
be especially advantageous when O2 availability is low.  This is supported by the findings of a 79 
recent study, in which nitrate supplementation improved tolerance to severe intensity cycling 80 
in hypoxia (FIO2 13.1 %) but not normoxia [36].  However, in other studies, nitrate 81 
supplementation has been shown both to improve [8,22,37] and have no effect [38–40] on 82 
hypoxic exercise performance.  These equivocal findings may be attributed to differences in 83 
the training status of participants, exercise protocol, supplementation protocol, and hypoxic 84 
stimuli applied, and warrant further exploration.   85 
 86 
Evidence from murine models suggests that the effects of dietary nitrate supplementation may 87 
be fibre type specific, increasing muscle perfusion and oxygenation [41,42], and enhancing 88 
calcium handling and force production [9] in type II muscle fibres only, as may be recruited 89 
during high-intensity exercise (for review, see Jones et al. [43]). Moreover, nitrate 90 
supplementation has been demonstrated to elicit beneficial effects when the contribution of 91 
type II muscle towards force generation is high, including at fast but not slow muscle 92 
contraction frequencies [44], and during the transition from moderate to severe but not 93 
unloaded to moderate intensity exercise [45].   94 
 95 
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It is possible that nitrate supplementation is especially effective when conducting high-96 
intensity exercise in a hypoxic environment, such that individuals across a range of aerobic 97 
fitness levels may derive a similar performance enhancing benefit from dietary nitrate 98 
supplementation.  This has considerable relevance, given the widespread popularity of travel 99 
to high-altitude (i.e. hypobaric hypoxia) each year for recreational (e.g. hiking, skiing, 100 
mountaineering) and sporting (e.g. training camps, high-altitude running events, and cycle 101 
mountain stages) purposes in individuals with a range of different fitness levels.  Therefore, 102 
the purpose of this study was to assess the effect of nitrate supplementation on physiologica l 103 
functioning and TT performance in moderate normobaric hypoxia (equivalent to 2500 m) in 104 
individuals with varying aerobic fitness levels (VO2max).  We hypothesised that: (1) dietary 105 
nitrate supplementation would enhance exercise performance in hypoxia and (2) this effect 106 
would be consistent across a range of aerobic fitness levels.  107 
 108 
2. Methods 109 
2.1 Participants 110 
Twelve healthy men aged 24.4 ± 4.3 years, with a body mass of  76.4 ± 9.6 kg, stature of 181.6 111 
± 6.4 cm, and maximal O2 uptake (V̇O2max) at sea-level (normoxia) of 62.1 ± 9.3 ml·kg-1·min-112 
1 (range: 47.1 to 76.8 ml·kg-1·min-1) and simulated altitude (2500 m) of 52.2 ± 7.5 ml·kg-1·min-113 
1 (range: 40.8 to 61.8 ml·kg-1·min-1) volunteered to take part in this study.  Participants were 114 
recruited across a range of aerobic fitness levels to assess the relationship between V̇O2max and 115 
the change in hypoxic exercise performance consequent to nitrate supplementation. The 116 
participant cohort comprised six competitive runners / triathletes (all with experience racing 117 
over 1500 m), four individuals who regularly took part in recreational sport but were not 118 
competitive athletes, and two individuals who were physically active, yet did not take part in 119 
any sport.  The study received institutional ethical approval and was conducted in accordance 120 
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with the Declaration of Helsinki. Participants provided written informed consent prior to 121 
testing.  122 
 123 
2.2 Overview 124 
Participants visited the laboratory on five occasions within a six week period. On the first visit 125 
to the laboratory, participants completed an incremental running test to volitional exhaustion 126 
in normoxia to determine V̇O2max. The values obtained were used to define training status.   127 
Each subsequent session involved exercise in a normobaric hypoxic chamber (TISS, Alton, 128 
UK, and Sporting Edge, Sherfield on Loddon, UK) situated at ~ 113 m above sea-level at a 129 
simulated altitude of 2500 m (FIO2 ~ 15.0 %).  FIO2 was adjusted daily based around 130 
fluctuations in barometric pressure, and accounting for 47 mmHg water vapour pressure [46].  131 
Ambient air temperature and relative humidity were maintained at 20 °C and 50 % respectively.   132 
On the second visit to the laboratory, participants completed an incremental running test in 133 
hypoxia, to define altitude specific V̇O2max, and elucidate suitable relative exercise intensit ies 134 
for the experimental trials. The third visit involved a familiarisation session, replicating the 135 
experimental trials but without any intervention. The fourth and fifth visits constituted the 136 
experimental trials.  Experimental trials were preceded by the consumption of 138 ml 137 
concentrated nitrate-rich (BRJ) (~ 15.2 mmol nitrate) or nitrate-deplete (PLA) (~ 0.2 mmol 138 
nitrate) beetroot juice (BEET IT, James White Drinks Ltd., Ipswich, UK), administered in a 139 
randomised double-blind cross-over design three hours before exercise.  Participants were 140 
asked to abstain from intense exercise, alcohol, and caffeine for 24 hours prior to each trial. 141 
Antibacterial mouthwash and chewing gum, known to ablate the oral bacteria responsible for 142 
nitrate reduction into nitrite, was also avoided [47].    143 
 144 
 145 
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2.3. Preliminary trials 146 
A two-part incremental running test was conducted on a motorised treadmill (Woodway, 147 
Cranlea, Birmingham, UK) [48], once in normoxia and once in normobaric hypoxia. 148 
Participants completed five to eight sub-maximal stages lasting three minutes, separated with 149 
one minute recovery periods. Starting speed was determined based around perceived 150 
participant fitness.  Running speed was increased by 1 km·h-1 each stage, and a 1 % treadmill 151 
gradient was applied to approximate the energetic cost of outdoor running [49].  Finger- tip 152 
blood samples were obtained between stages to determine blood lactate concentration (YSI 153 
2300 STAT plus, Yellow Springs, Ohio).  Exercise was ceased when blood lactate 154 
concentration reached 4 mM.   The second phase of the test commenced following 5 minutes 155 
recovery.  A fixed running speed equal to the final speed obtained during the first part of the 156 
test, minus 2 km·h-1 was applied. The gradient was increased by 1 % every minute, until 157 
volitional exhaustion. Respiratory variables were monitored continuously via an online gas 158 
analysis system, calibrated before each trial according to the manufacturer’s instruct ions 159 
(MedGraphics Ultima CPX, MGC Diagnostics, MN, USA).  160 
 161 
2.4. Experimental trials 162 
2.4.1. Protocol 163 
On the morning of each experimental session, participants arrived at the laboratory between 7 164 
and 9 am following an overnight fast. A cannula was fitted by a trained phlebotomist into a 165 
vein in the arm to enable repeated blood sampling.  Participants then ingested BRJ or PLA 166 
within a 5 minute period and consumed a standardised breakfast (360 kcal, carbohydrates 62 167 
%, fat 22 %, protein 16 %) within a 10 minute period.  They then rested in normoxia for 2.5 168 
hours, during which time water was permitted ad libitum.  Participants then entered the hypoxic 169 
chamber, where they rested for a further 30 minutes.  Exercise commenced 3 hours post-170 
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supplementation, and included 2 x 15 minute bouts of steady-state running at 45 % and 65 % 171 
altitude-specific V̇O2max, each followed by a 5 minute recover period.  A 1500 m TT then 172 
commenced.  Participants ran at a speed approximating 80 % altitude-specific V̇O2max for 30 173 
seconds as a ‘rolling start’, before the TT commenced. Participants were asked to run the 1500 174 
m TT as fast as possible. Running speed and time were not visible during the TT, although 175 
participants were informed of the distance they had covered at 200 m intervals.  The treadmill 176 
gradient was set to 1 % throughout exercise [49].  We have previously demonstrated excellent 177 
reliability of this performance test (CV < 1 %)[50].  Participants rested in normobaric hypoxia 178 
for 10 minutes following TT, after which they were free to leave.   179 
 180 
2.4.2. Measurements 181 
Ten blood samples were drawn throughout each experimental trial, comprising two, 4 ml 182 
lithium heparin containing vacutainers (Becton Dickinson, Plymouth, UK) for later 183 
determination of plasma nitrate and nitrite.  Measurement points included pre-supplementat ion, 184 
30, 60, 90, 120, 150 (pre-hypoxic exposure), and 180 (pre-exercise) minutes post-185 
supplementation, following each bout of steady-state exercise, and immediately post-TT.  186 
Blood pressure (BP) of the brachial artery was measured using an automated 187 
sphygmomanometer (Omron Healthcare Ltd., Kyoto, Japan) pre-supplementation, pre-hypoxic 188 
exposure, pre-exercise, and 5 minutes post-TT.  Mean arterial pressure (MAP) was calculated 189 
as 1/3·systolic pressure + 2/3·diastolic pressure [51].  At the same time points, a measure of 190 
exhaled NO was also recorded, using a hand-held electrochemical analyser (NObreath, Bedfont 191 
Scientific Ltd., UK).  Four measures were obtained for BP and exhaled NO, and the mean value 192 
of the final three measurements was used for data analysis.  Heart rate (HR) was measured via 193 
a chest worn heart-rate monitor strap (Polar Electro, Oy, Finland) pre-supplementation, pre-194 
hypoxic exposure, pre-exercise, during the final 2 minutes of each steady-state exercise bout, 195 
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and immediately post-TT.  Arterial O2 saturation (SaO2) was monitored via pulse oximetery 196 
(Nellcor, Medtronic, Minneapolis, MN) pre-hypoxic exposure, pre-exercise, during the final 2 197 
minutes of each steady-state exercise bout, and immediately post-TT.  Expired gas was 198 
monitored as previously described for 10 minutes pre-exercise, and during steady-state 199 
exercise.  Data obtained during the final 5 minutes of rest and each steady-state exercise bout 200 
was averaged and used for subsequent analysis.   Perceptions of exertion were also monitored 201 
during the final 2 minutes of each steady-state exercise bout and immediately post-TT using a 202 
15 point (6 – 20) ratings of perceived exertion (RPE) scale [52]. 203 
 204 
2.5. Assessment of NO blood metabolites 205 
2.5.1. Blood handling 206 
Blood samples were centrifuged at 5000 rpm for 3 minutes immediately post-collection.  207 
Plasma (1 ml) was drawn from each vacutainer into opaque cryotubes (Argos Technologies, 208 
IL, USA), each containing 6.5 mM N-ethylmaleimide (NEM) and 0.1 mM 209 
Diethylenetriaminepentaacetic acid (DTPA).  NEM and DTPA were added to prevent the 210 
interchange between NO metabolites [53]. Cryotubes were immediately placed in a freezer at 211 
– 80 ˚C, for later analysis of nitrate and nitrite.  1 ml was also extracted from each 70 ml 212 
beetroot juice ‘shot’ prior to administration, and frozen in untreated opaque cryotubes at – 80 213 
ºC for subsequent determination of nitrate concentration.   214 
 215 
2.5.2. Ozone-based chemiluminescence 216 
Plasma nitrate and nitrite concentration, and the nitrate content of administered beetroot juice  217 
were measured by ozone-based chemiluminescence as per the manufacturer’s instruct ions 218 
(Sievers NOA 280i, Analytix, UK). Briefly, nitrite was determined by addition of samples to 219 
0.17M sodium iodide in glacial acetic acid under nitrogen at room temperature. Sodium iodide 220 
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in acetic acid has the capacity to convert nitrite to NO, but is unable to reduce any higher oxides 221 
of nitrogen such as nitrate and thus is relatively specific for nitrite. To obtain concentration of 222 
total plasma nitrogen oxides (NOx), we used the same apparatus with a stronger reducing agent 223 
vanadium chloride (0.1M) in hydrochloric acid (1M) at 95 °C. These stronger conditions reduce 224 
the sum of all nitrogen oxides, which is predominantly nitrate (μM) but also includes both 225 
nitrite (nM) and nitrosothiols (nM). Nitrate concentration was calculated by subtraction of the 226 
nitrite from NOx. 227 
 228 
2.6. Statistical analysis 229 
Data analysis was conducted using SPSS version 22.  An α level of p < 0.05 was accepted for 230 
significance. Normality was assessed using the Shapiro-Wilk test. Non-normal data was log-231 
transformed (log10) prior to analysis.  Physiological data was compared between trials using a 232 
two-way (time and condition) ANOVA. To adjust for asphericity, the Greinhouse Geisser 233 
correction was applied for ε < 0.75, and the Huynh-Feldt correction was adopted for ε > 0.75.  234 
Post-hoc analysis was conducted using t-tests with a Bonferroni adjustment. A paired t-test was 235 
used to compare TT performance between conditions. The square of Pearson’s correlation 236 
coefficient (r2) was used to explicate the relationship between variables. A statistica l 237 
spreadsheet was also used to derive a qualitative probabilistic inference for performance data 238 
[54].  One of the following verbal descriptors was assigned to describe the likelihood of a 239 
practically beneficial effect of BRJ on performance: < 0.5 %, ‘almost certainly not’; 0.5 – 5 %, 240 
‘very unlikely not’; 5 – 25 %, ‘unlikely’; 25 – 75 %, ‘possibly’; 75 – 95 %, ‘likely’; ’95-99.5 241 
%’, ‘very likely’; > 99.5 %, ‘almost certainly’.  Data are presented as means ± SD, unless 242 
otherwise stated.     243 
 244 
 245 
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3. Results 246 
3.1. Plasma nitrate and nitrite and exhaled NO 247 
Plasma nitrate, nitrite and exhaled NO data are presented in Figure 1.  Pre-supplementa t ion 248 
plasma nitrate concentration was no different between BRJ (28.8 ± 14.3 µmol·L-1) and PLA 249 
(30.1 ± 29.4 µmol·L-1) (p > 0.05). There was a marked increase in plasma nitrate concentration 250 
(i.e. a condition effect) in BRJ (493.0 ± 174.4 µmol·L-1) versus PLA (32.5 ± 34.6 µmol·L-1, p 251 
< 0.01). Significant effects for time (p < 0.001) and time * condition interaction effects (p < 252 
0.001) were observed. Post-hoc analysis revealed significantly elevated plasma nitrate 253 
concentration in BRJ compared to PLA and pre-supplementation baseline values, 30 minutes 254 
post-supplementation, and at all subsequent measurement points (p < 0.001).  Peak plasma 255 
nitrate concentration occurred on average approximately 2 hours post-supplementation (BRJ = 256 
594.1 ± 90.5 vs. PLA = 33.9 ± 35.6 µmol·L-1, p < 0.001).  Plasma nitrate concentration was 257 
unchanged relative to pre-supplementation in PLA (p > 0.05).   258 
 259 
Pre-supplementation plasma nitrite concentration did not differ between BRJ (87.5 ± 65.7 260 
nmol·L-1) and PLA (91.7 ± 70.8 nmol·L-1) (p > 0.05). Conversion of nitrate into nitrite was 261 
evident, with a significant effect of condition on plasma nitrite concentration (BRJ: 468.0 ± 262 
252.5 vs. 105.4 ± 57.5 nmol·L-1, p < 0.001). Significant effects for time (p < 0.001) and time * 263 
condition interaction effects (p < 0.001) were observed. Post-hoc analysis revealed that plasma 264 
nitrite was significantly greater in BRJ versus PLA and pre-supplementation baseline values, 265 
1 hour post-supplementation (p < 0.01), and remained higher in BRJ across all subsequent 266 
measurement points (p < 0.001).   Peak plasma nitrite concentration occurred on average 267 
approximately 2.5 hours post-supplementation (BRJ = 660.4 ± 265.0 vs. PLA = 109.7 ± 61.0 268 
nmol·L-1, p < 0.001).  Plasma nitrite concentration was unchanged relative to pre-269 
supplementation values in PLA (p > 0.05).   270 
12 
 
Pre-supplementation concentration of exhaled NO was no different between BRJ (32.1 ± 34.7 271 
p.p.b.) and PLA (36.8 ± 31.5 p.p.b.) (p > 0.05).  There was a significant condition effect on 272 
exhaled NO (BRJ = 54.1 ± 39.8 vs. PLA = 33.6 ± 31.1 p.p.b., p = 0.002).  Significant effects 273 
for time (p = 0.021) and time * condition interaction effects (p = 0.002) were observed. Post-274 
hoc analysis revealed exhaled NO was significantly elevated in BRJ compared with PLA and 275 
pre-supplementation values at all post-supplementation measurement points (p < 0.05), but 276 
were unchanged in PLA (p > 0.05).   277 
 278 
 279 
 280 
 281 
 282 
 283 
 284 
 285 
 286 
 287 
 288 
 289 
 290 
 291 
 292 
 293 
 294 
 295 
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 296 
Figure 1 Exhaled NO (A), Plasma nitrite (B) and plasma nitrate (C) throughout experimental trials in the placebo (PLA) (dashed lines) and 297 
nitrate-rich beetroot juice (BRJ) (solid lines) conditions.  Values are mean ± SEM.  * T ime points significantly different between BRJ and 298 
PLA conditions (p < 0.05). 
# 
Time points significantly different from baseline in the BRJ condition.   299 
 300 
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3.2. Perceived exertion and cardio-respiratory variables 301 
Data for RPE, HR, MAP, V̇O2, and SaO2 is presented in Table 1.  There was a significant 302 
condition effect for RPE (BRJ: 13 ± 4 vs. PLA: 14 ± 4, p = 0.037), and a clear effect of time 303 
on RPE (p < 0.001), although no time * condition interaction effects were observed (p = 0.152).  304 
There was a significant time effect on HR (p < 0.001), but no condition (p = 0.495) or time * 305 
condition interaction effects (p = 0.383) were observed. MAP showed a significant effect of 306 
condition (BRJ: 83 ± 7 vs. PLA: 86 ± 7 mmHg, p = 0.006), but no time (p = 0.187) or time * 307 
condition interaction effects (p = 0.646).  There was a significant effect of condition on V̇O2 308 
(BRJ: 18.4 ± 12.0 vs. 20.4 ± 12.6 ml·kg-1·min-1, p = 0.002).  Likewise, there were significant 309 
effects of time (p < 0.001) and time * condition interaction effects (p = 0.005) on V̇O2.  Post-310 
hoc analysis revealed significantly lower V̇O2 in BRJ during exercise at 45 % (p = 0.014) and 311 
65 % (p = 0.002) V̇O2max.  There was a significant effect of condition (BRJ: 88 ± 3 vs. PLA: 312 
87 ± 3 %, p < 0.001), time (p < 0.001) and time * condition interaction effects (p = 0.034) on 313 
SaO2.   Post-hoc analysis revealed significant differences in SaO2 during the pre-exercise rest 314 
period (p = 0.012) and during exercise at 45 % V̇O2max (p = 0.003). There was no significant 315 
relationship between the reduction in V̇O2 and increase in SaO2 consequent to BRJ (r2 = 0.13, 316 
p = 0.242).   317 
 318 
 319 
 320 
 321 
 322 
 323 
 324 
 325 
 326 
 327 
 328 
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Table 1 Ratings of perceived exertion, heart rate, mean arterial blood pressure, oxygen consumption, and arterial oxygen saturation 329 
throughout experimental trials in the placebo (PLA) and nitrate-rich beetroot juice (BRJ) conditions 330 
Variable and 
condition 
Arrival Pre-
exposure 
Pre-
exercise 
45 % 
V̇O2max 
65 % 
V̇O2max 
TT 
RPE        
PLA    10 ± 1 12 ± 1 19 ± 1 
BRJa    9 ± 1 12 ± 1 19 ± 1 
 
HR  
(b·min-1) 
      
PLA 61 ± 8 60 ± 9 58 ± 9 107 ± 16 146 ± 13 183 ± 9 
BRJ 58 ± 9 60 ± 8 59 ± 7 105 ± 18 144 ± 12 183 ± 8 
 
MAP 
(mmHg) 
      
PLA 87 ± 8 86 ± 5 85 ± 7   85 ± 10 
BRJa 87 ± 10 81 ± 10 83 ± 7   82 ± 5 
 
VO2  
(ml·kg-1·min-1) 
      
PLA   4.8 ± 1.0 21.4 ± 6.0 33.7 ± 4.3  
BRJa   4.5 ± 0.7 19.2 ± 
5.9b 
31.4 ± 
3.9b 
 
SaO2 
(%) 
      
PLA  98 ± 1 91 ± 3 85 ± 2 81 ± 3 78 ± 7 
BRJa  97 ± 2 94 ± 2b 88 ± 2 b 83 ± 2 80 ± 6 
a denotes significant difference overall (condition effect) versus PLA 331 
b denotes significant difference (time * condition interaction effect) versus PLA 332 
 333 
3.5. TT performance 334 
BRJ improved 1500 m TT performance by 3.2 % (BRJ = 331.1 ± 45.3 s) versus PLA (341.9 ± 335 
46.1 s, p < 0.001). Magnitude based inferences [54] indicated that the true value of the effect 336 
would ‘almost certainly’ be practically beneficial to an athlete. All 12 participants completed 337 
the TT quicker following BRJ ingestion (Figure 2.), with the range of improvement between 338 
1.1 and 20.2 s.  There was no significant correlation between V̇O2max measured at sea-level (r2 339 
= 0.05; p = 0.48) nor simulated-altitude (r2 = 0.05, p = 0.46) and the change in performance 340 
following BRJ supplementation.  The observed r2 value indicates that 5 % of the 1500 m TT 341 
variability can be explained in terms of differences in V̇O2max.  There was no significant 342 
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correlation between the change in VO2 (r2 = 0.04, p = 0.84) nor SaO2 (r2 = 0.001, p = 0.90) and 343 
the change in performance following BRJ.   344 
 345 
 346 
Figure 2 1500 m TT performance following ingestion of placebo (PLA) or nitrate-rich beetroot juice (BRJ). 347 
 348 
4. Discussion 349 
Nitrate-rich beetroot juice has emerged as a popular ergogenic aid, although previous research 350 
suggests that this supplement has limited effects in well-trained individuals (V̇O2max > 60 351 
ml·kg-1·min-1).  In contrast, the results of this study suggest that nitrate-rich beetroot juice may 352 
reduce the O2 cost of exercise, elevate SaO2, and enhance 1500 m TT performance in 353 
individuals across a range of different fitness levels exercising in moderate-normobar ic 354 
hypoxia.  These data have relevance for the thousands of recreational and competitive athletes 355 
ascending to altitude each year for sporting purposes.   356 
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4.1. Plasma nitrate, nitrite, and exhaled NO 357 
Consistent with previous investigations, plasma nitrate and nitrite, and exhaled NO 358 
concentrations were significantly elevated following dietary nitrate supplementa t ion 359 
[1,2,5,8,55,22,39,38], signifying an increase in the ‘substrates’ available for NO generation via 360 
the nitrate-nitrite-NO pathway [11].  Peak plasma nitrite concentration was 602 % higher in 361 
BRJ versus PLA, similar to Arnold et al. [38] (775 %) (~ 7 mmol nitrate), but considerably 362 
greater than reported by Muggeridge et al. [22] (134 %) (~ 5 mmol nitrate) and Vanhatalo et 363 
al. [8] (150 %) (~ 9.3 mmol).  Importantly, all participants increased plasma nitrite 364 
concentration by substantially greater than 30 % - a cut off proposed by Wilkerson [20] for 365 
identifying ‘non-responders’. This may, in part, be a consequence of the high nitrate dose 366 
administered, and may help explain the consistent ergogenic effect observed in this study. 367 
Nevertheless, there was substantial inter-individual variability in baseline plasma nitrite 368 
concentration (range: 40 – 300 nmol·L-1), the magnitude of the increase in plasma nitrite 369 
concentration post-supplementation (∆ range: 160 – 1335 nmol·L-1), and the time at which 370 
peak plasma nitrite concentration occurred (1 – 3 hours post-supplementation).  A variable 371 
response to nitrate supplementation has been well-reported in the literature [56].  Inter-372 
individual differences could not be explained by participant aerobic fitness in this study. 373 
Genetic factors, chronobiology, variations in the quantity and/or taxa of oral nitrate reducing 374 
bacteria, and study protocol variables may be important in explaining this phenomenon, and 375 
require further investigation [56].   376 
 377 
4.2. Effect of nitrate supplementation on cardiorespiratory variables  and RPE 378 
In the present study, V̇O2 did not differ significantly between BRJ and PLA during rest in 379 
hypoxia, but was significantly lower in BRJ versus PLA during steady-state exercise. These 380 
findings are in line with most previous investigations [4,5,22,37], and similar to the results of 381 
18 
 
a recent meta-analysis [6].  The physiological mechanisms underlying the decreased V̇O2 382 
subsequent to nitrate supplementation have not been fully elucidated, but may be accounted for 383 
by: a) an improvement in the efficiency of mitochondrial respiration [35] and/or b) enhanced 384 
efficiency of muscle force production [7].   385 
 386 
Larsen and co-workers [35] reported an improvement in the phosphate/O2 (P/O) ratio (i.e. the 387 
amount of ATP produced per mole O2 consumed) in mitochondria harvested from the vastus 388 
lateralis of healthy men following three days supplementation with sodium nitrate (0.1 389 
mmol·kg-1·d-1). This effect was attributed to decreased proton leak during oxidative 390 
phosphorylation, and was associated with a reduced expression of the ATP/ADP translocase 391 
protein (ANT) and a tendency towards downregulation of uncoupling protein 3 (UCP3).  The 392 
change in the mitochondrial P/O ratio correlated with the reduced in vivo V̇O2 measured during 393 
moderate-intensity cycle ergometry.  In contrast to the findings of Larsen et al. [47] with 394 
sodium nitrate, a recent investigation by Whitfield and colleagues [57] reported no change in 395 
mitochondrial efficiency despite a reduced V̇O2, following seven days supplementation with 396 
nitrate-rich beetroot juice (26 mmol·d-1).  There is presently no explanation as to why sodium 397 
nitrate and nitrate-rich beetroot juice may have different effects on the mitochondria, and direct 398 
comparison is therefore warranted to rule out other methodological differences [58]. 399 
Nevertheless, alterations in mitochondrial efficiency are not necessarily required to explain the 400 
reduction in V̇O2 reported in this study following BRJ supplementation.   401 
 402 
Bailey et al. [7] reported reduced intramuscular PCr, ADP, and Pi perturbations and lower V̇O2 403 
during leg extension exercise following nitrate-rich beetroot juice supplementation (5.1 404 
mmol·d-1 x 6 days), reflecting a lower ATP turnover for a given work rate. It was suggested 405 
that the decreased ATP turnover occurring after nitrate supplementation might be related to a 406 
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reduced ATP requirement for actin-myosin cross-bridge cycling and/or calcium handling, 407 
given previous reports that NO slows actin-myosin cross-bridge cycling [59,60] and inhib its 408 
calcium-ATPase activity [61,62].  Interestingly, a recent murine model investigation reported 409 
greater force production, and increased expression of the calcium handling protein 410 
calsoquestrin 1 and the dihydropyridine receptor in type II muscle fibres following nitrate 411 
supplementation [9].  It was speculated that such effects in humans may allow muscle 412 
activation at a lower frequency for an equivalent force production, lowering motor unit 413 
recruitment and concomitantly the ATP cost of exercise.   414 
 415 
In the present study, SaO2 was significantly elevated overall in BRJ compared to PLA.  These 416 
findings are similar to those of Masschelein and colleagues [37] who reported a significant 417 
increase in SaO2 during cycle ergometry exercise in severe hypoxia (FIO2 11 %) following 6 418 
days nitrate supplementation (~ 5 mmol·d-1).  Tissue oxygenation in the vastus lateralis was 419 
also elevated following nitrate supplementation in that study. These findings are supportive of 420 
the notion that nitrate supplementation may reduce muscle O2 consumption during exercise in 421 
hypoxia, presumably via the aforementioned mitochondrial [35] and/or muscle [7] alterations 422 
that also manifest as a reduced V̇O2. Interestingly, Arnold et al. [38] found that runners 423 
identified as ‘responders’ to nitrate supplementation during a 10,000 m TT in moderate hypoxia 424 
(FIO2 15.4 %) typically experienced a lower SaO2 during the placebo TT than ‘non-responders’ 425 
(82 vs 84 %).  This suggests that the SaO2 response to hypoxia may moderate the performance 426 
effects of nitrate supplementation, possibly due to greater nitrite reduction into NO at lower O2 427 
tensions [33]. In this study, there was no apparent relationship between average nor post-TT 428 
SaO2 values and the percentage improvement in performance (r2 = 0.05).  However, SaO2 429 
reached lower values in the present investigation (post TT PLA: 77.8 ± 6.9 %) than observed 430 
20 
 
by Arnold et al. [38], presumably due to the shorter higher- intensity TT, which may be 431 
important.     432 
 433 
Interestingly, RPE was significantly lower overall in BRJ versus PLA, suggesting reduced 434 
overall physiological ‘strain’ [52], which may in part be reflective of the lower V̇O2 and/or 435 
elevated SaO2 with BRJ. In normoxia, Murphy and colleagues [63] reported lower RPE during 436 
the first mile of a 5 km running TT, although others have reported no effect of nitrate 437 
supplementation on RPE during sub-maximal and maximal exercise in hypoxia following 438 
nitrate supplementation [37,38].   439 
 440 
4.3. Effect of nitrate supplementation on running performance in hypoxia 441 
The main finding of the present study was that BRJ improved 1500 m running performance in 442 
moderate normobaric hypoxia by 3.2 % versus PLA.  Magnitude based inferences suggested 443 
an ‘almost certain’ chance that the true value of the effect would be practically beneficial. In 444 
agreement with our hypothesis, there was no apparent relationship between the change in 445 
exercise performance post-BRJ supplementation and V̇O2max measured in normoxia nor 446 
hypoxia, suggesting a similar effect of BRJ on TT performance across a range of fitness levels 447 
under these experimental conditions. 448 
 449 
A number of previous investigations have confirmed the beneficial effect of nitrate 450 
supplementation on TTE [8,24,37] and TT performance [22] in hypoxia.  Conversely, studies 451 
in well-trained individuals exercising in hypoxia have typically found no effect of nitrate 452 
supplementation [38–40]. Well-trained individuals exhibit increased presence and activity of 453 
the NOS enzymes [31]; possess higher baseline nitrate/nitrite concentration [29]; may 454 
habitually consume high levels of nitrate as a consequence of their large daily energy intake 455 
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[30]; and experience lower tissue acidosis and hypoxia [20] relative to the untrained.  456 
Moreover, a recent investigation in normoxia observed an inverse correlation between aerobic 457 
fitness and the response to nitrate supplementation [17]. It is therefore reasonable to assume 458 
that adaptations elicited by endurance training may blunt the response to nitrate 459 
supplementation.    Nevertheless, our results suggest a high training status does not necessarily 460 
preclude an ergogenic effect of nitrate supplementation.  Instead, it is suggested that individua ls 461 
across a spectrum of aerobic fitness levels may derive similar performance enhancing benefits 462 
of nitrate supplementation under specific experimental conditions, including a hypoxic 463 
exercise environment, short-duration high-intensity TT protocol, and high nitrate dose.   464 
 465 
Considering generation of NO via the L-arginine NOS pathway is supressed in hypoxia, yet 466 
the nitrate-nitrite-NO pathway is potentiated as O2 tensions fall [11,33], it is likely that nitrate 467 
supplementation is more effective in hypoxia than normoxia.  Supportive evidence is provided 468 
by Kelly et al. [36], who subjected healthy male participants to identical exercise regimes 469 
preceded by the same nitrate supplement strategy (8.4 mmol·d-1 x 3 days), but with exercise 470 
varied between normoxia and hypoxia (FIO2 13.1 %).  Nitrate supplementation had no effect 471 
on severe-intensity cycling TTE in normoxia, but improved TTE by ~ 8.6 % in hypoxia relative 472 
to placebo.  Further, there is evidence from murine model investigations that nitrate 473 
supplementation may enhance tissue blood flow [41,42] and muscle contractile function [9] 474 
preferentially in type II muscle fibres.  It is therefore possible that nitrate supplementation is 475 
more effective during shorter more high-intensity exercise, during which these muscle fibres 476 
are more heavily recruited [9,43–45,64], or else in individuals with greater distribution of type 477 
II muscle fibres [43].  The time-trial duration employed in this study (< 6 minutes) was 478 
considerably less than other investigations (~ 17 - 48 minutes) which have not observed an 479 
ergogenic effect of nitrate supplementation in hypoxia [38–40], and may be important. Thus, 480 
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the combination of a hypoxic exercise environment and high-intensity TT may have maximised 481 
the effects of nitrate supplementation.   482 
 483 
Finally, there is some evidence of a dose-response to nitrate supplementation [55,65,66], and 484 
it is possible that well-trained athletes may require a high nitrate dose to appreciably alter 485 
plasma nitrite concentration relative to untrained individuals [30].  Therefore, the high nitrate 486 
dose administered in this study relative to investigations which have not observed an effect of 487 
nitrate supplementation (~ 5 – 7 mmol) [38–40] may have also contributed towards the 488 
consistent ergogenic effect observed here.   489 
 490 
4.4. Strengths and limitations 491 
The current study has several strengths.  In particular, the broad spectrum of participant aerobic 492 
fitness levels allowed us to assess the relationship between V̇O2max and the improvement in 493 
hypoxic exercise performance following nitrate supplementation.  Nevertheless, none of our 494 
participants were elite athletes nor entirely sedentary, and it is possible that individuals outside 495 
of the present fitness range may respond differently to nitrate supplementation.  Moreover, we 496 
only included healthy male participants, and further research is warranted in other populations 497 
who may respond differently to nitrate supplementation [67].  A further strength of this 498 
investigation was that the consumption of nitrate-rich foods was not restricted during the study 499 
period.  This approach, first employed by Vanhatalo and colleagues [51] and later adopted in 500 
several subsequent investigations [25,68], preserves ecological validity and demonstrates that 501 
nitrate supplementation can alter physiological functioning and exercise performance when 502 
participants are consuming their normal diet.    503 
 504 
 505 
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4.5. Conclusion 506 
The present study reported an increase in plasma nitrite concentration, reduction in steady-state 507 
V̇O2, elevation in SaO2, and enhancement of 1500 m running performance in normobaric 508 
hypoxia following supplementation with dietary nitrate.  Further, this effect did not appear to 509 
be related to the aerobic fitness of participants.  This suggests that individuals across a range 510 
of different aerobic fitness levels may derive a similar performance enhancing benefits of 511 
dietary nitrate when consuming a high nitrate dose, and conducting moderate and high-intens ity 512 
exercise in a hypoxic environment.   513 
 514 
 515 
 516 
 517 
 518 
 519 
 520 
 521 
 522 
 523 
 524 
 525 
 526 
  527 
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